Scientists will receive £8million to boost their ground-breaking work at the Cancer Research UK Glasgow Centre.

Glasgow was chosen by an international panel of experts as one of just 13 locations to secure funding in the latest review of the Cancer Research UK Centres network.

The Glasgow centre is a world leader in pancreatic cancer research, turning discoveries into potential new treatments and testing them in clinical trials.

Survival among pancreatic cancer patients is low, but the clinical research in Glasgow could play a key role in changing this and improving patients’ chances of beating the disease.

Research in Glasgow is also focused on bowel and ovarian cancer, leukaemia, and, as told in the Evening Times, work on pancreatic cancer such as that headed up by Professor Jeff Evans.

Professor Owen Sansom, interim director at the Cancer Research UK Beatson Institute, said: “This investment is fantastic news for cancer research in Glasgow.

“The city is home to a thriving community of world class cancer scientists and doctors, who are working to reduce the devastating impact of this disease, not only locally, but around the world.

“This award means we will be able to further develop our work in translational research – getting cutting-edge discoveries from the laboratory to patients and learning as much as possible from patients to initiate new research.”

With the funding, to be given over five years, the Centre will build on Glasgow’s world class research in the areas of drug discovery and understanding how cancer spreads around the body, as well as its strong expertise in the genetics underpinning cancer and looking at ways to make treatments more precise.

The Glasgow scientists are also working to make new discoveries in fundamental cell biology, and helping translate them into new treatments.